Advanced in Partial Familial Epilepsy

Weiping Liao

Key Laboratory Of Neurogenetics And Channelopathies Of Guangdong Province And The Ministry Of Education Of China, 
Guangzhou, CN 
Advanced in Partial Familial Epilepsy
Key Laboratory Of Neurogenetics And Channelopathies Of Guangdong Province And The Ministry Of Education Of China, 
Guangzhou, CN 
OverviewLocationsClinical Research

Overview

Weiping Liao practices in Guangzhou, China. Liao is rated as an Advanced expert by MediFind in the treatment of Partial Familial Epilepsy. Their top areas of expertise are Epilepsy, Partial Familial Epilepsy, Genetic Epilepsy with Febrile Seizures Plus (GEFS+), and Oculofaciocardiodental Syndrome.

Their clinical research consists of co-authoring 41 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Partial Familial Epilepsy.

Locations

Key Laboratory Of Neurogenetics And Channelopathies Of Guangdong Province And The Ministry Of Education Of China, Guangzhou, 510260, China
Other Locations
Foshan, China
Changgang Dong Road 250#, Changgang, 510260, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Young Adult Subjects With Dravet Syndrome (DS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Young Adult Subjects With Dravet Syndrome (DS)
Enrollment Status: Completed
Publish Date: January 01, 2025
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)
Enrollment Status: Completed
Publish Date: August 21, 2024
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
View 1 Less Clinical Trial

41 Total Publications

Precision gene diagnosis and treatment of epilepsy: a new frontier in medical care.
Precision gene diagnosis and treatment of epilepsy: a new frontier in medical care.
Journal: Acta epileptologica
Published: October 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Liao's expertise for a condition
ConditionClose
      View All 17 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile